Update – the voting sheet is available.
The Committee was consulted from 14 December 2018 – 07 January 2019 on the draft Commission Implementing Decision granting an authorisation for certain uses of sodium chromate and potassium chromate under Regulation (EC) No 1907/2006 of the European Parliament and of the Council (Saes Getters S.p.A.).
Updated formats for applications for authorisation and review reports are now available on ECHA’s website. The formats are compatible with the updated opinion format of ECHA’s scientific committees, and instruct applicants on how to present their analysis of alternatives and socio-economic analysis when applying for continuing the use of a substance of very high concern. They will become mandatory for applications and review reports from 1 June 2019.
Update – the prior notification of a concentration has been published in the Official Journal.
Veronica Manfredi, Director of the European Commission’s Quality of Life Directorate at the Directorate General Environment, talks about EU measures to reduce air pollution and its impact on health, an issue in the global spotlight.
The falsification of medicines has remained a serious threat to public health in the EU for too long. As of tomorrow, the new rules on safety features for prescription medicines sold in the EU will apply.
From now on, the industry will have to affix a 2-D barcode and an anti-tampering device on the box of prescription medicines. The pharmacies – including on-line pharmacies – and hospitals will have to check the authenticity of medicines before dispensing to patients. This is the final step in the implementation of the Falsified Medicines Directive, adopted in 2011, aiming at guaranteeing the safety and quality of medicines sold in the EU.